Literature DB >> 21114950

Recursive subsetting to identify patients in the STAR*D: a method to enhance the accuracy of early prediction of treatment outcome and to inform personalized care.

Anthony Y C Kuk1, Jialiang Li, A John Rush.   

Abstract

OBJECTIVE: There are currently no clinically useful assessments that can reliably predict--early in treatment--whether a particular depressed patient will respond to a particular antidepressant. We explored the possibility of using baseline features and early symptom change to predict which patients will and which patients will not respond to treatment.
METHOD: Participants were 2,280 outpatients enrolled in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study who had complete 16-item Quick Inventory of Depressive Symptomatology-self-report (QIDS-SR16) records at baseline, week 2, and week 6 (primary outcome) of treatment with citalopram. Response was defined as a ≥ 50% reduction in QIDS-SR16 score by week 6. By developing a recursive subsetting algorithm, we used both baseline variables and change in QIDS-SR16 scores from baseline to week 2 to predict response/nonresponse to treatment for as many patients as possible with controlled accuracy, while reserving judgment for the rest.
RESULTS: Baseline variables by themselves were not clinically useful predictors, whereas symptom change from baseline to week 2 identified 280 nonresponders, of which 227 were true nonresponders. By subsetting recursively according to both baseline features and symptom change, we were able to identify 505 nonresponders, of which 403 were true nonresponders, to achieve a clinically meaningful negative predictive value of 0.8, which was upheld in cross-validation analyses.
CONCLUSIONS: Recursive subsetting based on baseline features and early symptom change allows predictions of nonresponse that are sufficiently certain for clinicians to spare identified patients from prolonged exposure to ineffective treatment, thereby personalizing depression management and saving time and cost. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00021528. © Copyright 2010 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21114950     DOI: 10.4088/JCP.10m06168blu

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  14 in total

1.  Effect of obstructive sleep apnea on response to cognitive behavior therapy for depression after an acute myocardial infarction.

Authors:  Kenneth E Freedland; Robert M Carney; Junichiro Hayano; Brian C Steinmeyer; Rebecca L Reese; Annelieke M Roest
Journal:  J Psychosom Res       Date:  2012-01-28       Impact factor: 3.006

2.  Change-Plane Analysis for Subgroup Detection and Sample Size Calculation.

Authors:  Ailin Fan; Rui Song; Wenbin Lu
Journal:  J Am Stat Assoc       Date:  2017-04-13       Impact factor: 5.033

3.  Entropy Learning for Dynamic Treatment Regimes.

Authors:  Binyan Jiang; Rui Song; Jialiang Li; Donglin Zeng
Journal:  Stat Sin       Date:  2019       Impact factor: 1.261

4.  Targeting treatments for depression: what can our patients tell us?

Authors:  A John Rush
Journal:  Epidemiol Psychiatr Sci       Date:  2016-04-05       Impact factor: 6.892

Review 5.  Personalized medicine in major depressive disorder -- opportunities and pitfalls.

Authors:  Diane B Miller; James P O'Callaghan
Journal:  Metabolism       Date:  2012-09-26       Impact factor: 8.694

6.  Linear Fitted-Q Iteration with Multiple Reward Functions.

Authors:  Daniel J Lizotte; Michael Bowling; Susan A Murphy
Journal:  J Mach Learn Res       Date:  2012-11       Impact factor: 3.654

7.  Efficient logistic regression designs under an imperfect population identifier.

Authors:  Paul S Albert; Aiyi Liu; Tonja Nansel
Journal:  Biometrics       Date:  2013-11-21       Impact factor: 2.571

Review 8.  Early switching strategies in antidepressant non-responders: current evidence and future research directions.

Authors:  Paul A Kudlow; Roger S McIntyre; Raymond W Lam
Journal:  CNS Drugs       Date:  2014-07       Impact factor: 5.749

9.  Prediction of short-term antidepressant response using probabilistic graphical models with replication across multiple drugs and treatment settings.

Authors:  Arjun P Athreya; Tanja Brückl; Elisabeth B Binder; A John Rush; Joanna Biernacka; Mark A Frye; Drew Neavin; Michelle Skime; Ditlev Monrad; Ravishankar K Iyer; Taryn Mayes; Madhukar Trivedi; Rickey E Carter; Liewei Wang; Richard M Weinshilboum; Paul E Croarkin; William V Bobo
Journal:  Neuropsychopharmacology       Date:  2021-01-15       Impact factor: 7.853

10.  Toward an online cognitive and emotional battery to predict treatment remission in depression.

Authors:  Evian Gordon; A John Rush; Donna M Palmer; Taylor A Braund; William Rekshan
Journal:  Neuropsychiatr Dis Treat       Date:  2015-02-26       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.